Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

@article{Thomas1994ComparativeSO,
  title={Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.},
  author={Howard Thomas and A S Lok and Vincente Carreno and Geoffrey Farrell and Hugo E Tanno and V{\'i}ctor P{\'e}rez and Geoffrey Dusheiko and Graham Cooksley and J C Ryff},
  journal={Journal of viral hepatitis},
  year={1994},
  volume={1 2},
  pages={139-48}
}
To determine the efficacy of interferon-alpha 2a in chronic active hepatitis B, 238 patients were randomly divided, into four groups: three groups received either 2.5 MIU m-2, 5.0 MIU m-2 or 10.0 MIU m-2, three times weekly by intramuscular injection for 12-24 weeks; and a control group received no treatment. Patients were followed for up to 12 months after… CONTINUE READING